We are live on ! Find out more
NVAX icon

Novavax
NVAX

Fund managers haven’t disclosed any holdings of NVAX yet.

NVAX Hedge Fund Activity: Q1 2026 in Review

257 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q1 2026, worth a combined $960M — up 21% from $792M a quarter earlier.

Buyers outnumbered sellers: 56 funds opened new NVAX positions and 25 closed out — a net gain of 31 holders — while 72 added to existing stakes and 72 trimmed.

The largest buyer was Coatue Management, opening a new position worth an estimated $34.8M. The largest seller was Morgan Stanley, cutting an estimated $28.5M.

  • 257 institutional investors held Novavax (NVAX) as of Q1 2026, up from 234 in Q4 2025.
  • Funds reported $960M of Novavax stock for Q1 2026, up 21% quarter-over-quarter.
  • 56 funds opened new Novavax positions in Q1 2026 and 25 closed out, a net change of +31 holders.
  • The largest Novavax buyer in Q1 2026 was Coatue Management, an estimated $34.8M added.
  • The largest Novavax seller in Q1 2026 was Morgan Stanley, an estimated $28.5M sold.

Based on aggregated 13F filings for Q1 2026.